Population survival impact of new targeted and immune based therapies for metastatic or unresectable melanoma
Introduction New classes of drugs for metastatic or unresectable melanoma (MM) have shown improved survival in randomized trials (e.g., anti-CTLA-4, anti-PD-1, BRAF/MEK inhibitors). We sought to describe uptake of these new drugs and their impact on population-based survival outcomes of MM. Objec...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Swansea University
2018-08-01
|
| Serija: | International Journal of Population Data Science |
| Online pristup: | https://ijpds.org/article/view/639 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|